会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明申请
    • NEEDLE GUIDE SYSTEM
    • 指针系统
    • WO2011094322A3
    • 2011-12-08
    • PCT/US2011022588
    • 2011-01-26
    • WARSAW ORTHOPEDIC INCMCKAY WILLIAM F
    • MCKAY WILLIAM F
    • A61M5/32A61M5/42A61M5/46
    • A61M5/46A61B17/3401A61B17/3403A61B2017/347
    • A needle guide system comprising a needle guide including at least one wall defining an internal cavity and an outside of the needle guide. A lock is connected to the needle guide. The lock is movable between a first and a second position. A needle is disposed in the internal cavity of the needle guide, the needle having a long axis and a tip. The needle is movable along the long axis with respect to the needle guide when the lock is in the first position and the needle is locked to the needle guide and the tip extends beyond the wall of the needle guide when the lock is in the second position. Visual indicia on the lock may indicate whether the lock is in the first or the second position.
    • 一种针引导系统,其包括针引导件,该引导件包括限定内腔的至少一个壁和针引导件的外侧。 一个锁连接到针导向器。 锁可在第一和第二位置之间移动。 针设置在针导向件的内腔中,针具有长轴和尖端。 当锁处于第一位置时,针可以相对于针引导件沿着长轴移动,并且当锁处于第二位置时针被锁定到针引导件并且尖端延伸超过针引导件的壁 。 锁上的可视标记可以指示锁是处于第一还是第二位置。
    • 28. 发明申请
    • DRUG DEPOT WITH ANCHOR
    • 药房与锚点
    • WO2010059378A2
    • 2010-05-27
    • PCT/US2009062591
    • 2009-10-29
    • WARSAW ORTHOPEDIC INCMCKAY WILLIAM F
    • MCKAY WILLIAM F
    • A61M5/14A61M31/00A61M37/00
    • A61M31/002A61K9/0024A61M37/0069
    • A drug depot implantable at or near a target tissue site beneath the skin of a patient is provided, the drug depot comprising a therapeutically effective amount of a drug; at least one line having a distal end and a proximal end, the proximal end of the line attached to the drug depot; an anchor attached to the distal end of the line and configured to limit movement of the drug depot at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutically effective amount of the drug over a period of at least one day. In some embodiments, the drug depot provided can include an effective amount of at least analgesic and/or at least one anti-inflammatory agent at or near a target site, and can reduce, prevent or treat inflammation and/or pain.
    • 提供可植入患者皮肤下方的目标组织部位处或附近的药物长效制剂,所述长效制剂包含治疗有效量的药物; 至少一条具有远端和近端的管线,所述管线的近端连接到药物贮库; 附接到所述线的所述远端并配置成限制所述药物贮库在所述目标组织部位处或附近的移动的锚,所述药物贮库能够在至少一天的时间内释放所述治疗有效量的所述药物 。 在一些实施方案中,所提供的长效制剂可以包括在靶位点处或附近的有效量的至少止痛剂和/或至少一种抗炎剂,并且可以减少,预防或治疗炎症和/或疼痛。